Frequencies for first 10,000 rows of lit_ref variable in demo2015q2 dataset : Literature Reference | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 9,349 93.49 93.49 , AHMADI T, AQUI N, SVOBODA J, NASTA .. | 1 0.01 93.50 , ASSELAH T. DACLATASVIR PLUS SOFOSBU.. | 1 0.01 93.51 , BARI A, ANASTASIA A, BOTTO B, PUCCI.. | 1 0.01 93.52 , BERNARD, R; BORY, M; BROWER, R ; CO.. | 1 0.01 93.53 , BOLLANI S, ZIGNEGO A, PASCASIO J, M.. | 1 0.01 93.54 , BONKOVSKY H, FONTANA R, LEE W, STOL.. | 1 0.01 93.55 , BONKOVSKY H, FONTANA R, LEE W, STOL.. | 1 0.01 93.56 , BOWMAN L, HORWEDEL T, DELOS SANTOS .. | 1 0.01 93.57 , CHOWDHARY K, BECKER K, BAEHRING J, .. | 1 0.01 93.58 , COHN A, DAKHIL S, SALEH M, PIPERDI .. | 1 0.01 93.59 , FISHKIN P. LAPLAN B. DRAKE M. KURT.. | 1 0.01 93.60 , FOULADI M, TURNER D, WETMOR C, HAWK.. | 1 0.01 93.61 , GHOSH S, ROY C, SAHA M, CHOUDHURY K.. | 1 0.01 93.62 , HAMES M, TSAI J, DAHLMAN K, TALBOTT.. | 1 0.01 93.63 , HOFFRNAN-CENSITS J, MAMTANI R, WALI.. | 1 0.01 93.64 , HONKANEN T, JANTUNEN E, JYRKKIO S ,.. | 1 0.01 93.65 , JARMUZEK W, MIGDAL M AND PRONICKI M.. | 1 0.01 93.66 , JENNE C, ZYGUN D, ROBERTS D, HILL M.. | 1 0.01 93.67 , JIN J, WANG S, WANG W, SONG Y, LIU .. | 1 0.01 93.68 , KIANI-ALIKHAN S, MANSON A, VERMA N,.. | 1 0.01 93.69 , KURTARAN B, INA A, PULLUKCU H, ULU .. | 1 0.01 93.70 , LISSANDRINI L, ZAMBELLO R, PAOLINI .. | 1 0.01 93.71 , MAYNARD-MUET M, LEBOSSE F, CARRAT F.. | 1 0.01 93.72 , MOUGHAN J, MILLER B, XIAO Y, JHING.. | 1 0.01 93.73 , MOUGHAN J, MILLER B, XIAO Y, JHING.. | 2 0.02 93.75 , NAKOUTI T AND AKRIVIADIS E. TUBERCU.. | 1 0.01 93.76 , NODIMAR C, TAUPIN J-C, SEBASTIEN L,.. | 1 0.01 93.77 , NOWARA E. HUMAN EPIDERMAL GROWTH FA.. | 1 0.01 93.78 , OKI E, EMI Y, SAEKI H, KUSUMOTO T, .. | 1 0.01 93.79 , OLSEN A, OLESEN J, ANDERSSON C, KOB.. | 1 0.01 93.80 , PALAIA R, ALBINO V, DI GIACOMO R, A.. | 1 0.01 93.81 , PAPACHRISTOU E, KAZAKOPOULOS P, PAP.. | 1 0.01 93.82 , SANADA Y, HIRATA Y, YAMADA N, WAKIY.. | 1 0.01 93.83 , SANADA Y, HIRATA Y, YAMADA N, WAKIY.. | 1 0.01 93.84 , SANDLER D ELIMINATING ANTIBIOTIC PR.. | 1 0.01 93.85 , SONG W, TU J, FENG G, MO C AND SHEN.. | 1 0.01 93.86 , SPECKS U, STONE J, MERKEL P, SEO P,.. | 1 0.01 93.87 , VISWANATHAN A, MOUGHAN J, MILLER B.. | 1 0.01 93.88 , VON WEIKERSTHAL L, STINTZING S, DEC.. | 1 0.01 93.89 , XU J, SHEN L, LIU T, GUO W, ZHANG W.. | 1 0.01 93.90 , YOO C, KIM J, RYOO B, PARK Y, PARK .. | 1 0.01 93.91 . DACLATASVIR PLUS SOFOSBUVIR FOR HCV.. | 1 0.01 93.92 . IMPORTANT SAFETY INFORMATION...IGUR.. | 1 0.01 93.93 . ISCHAEMIC COLITIS: CASE REPORT. REA.. | 1 0.01 93.94 . QUINAPRIL, CARTEOLOL AND PAROXETINE.. | 1 0.01 93.95 .. .. .. .;.:. | 1 0.01 93.96 ABADIE D, DURRIEU G, ROUSSIN A, MONTA.. | 1 0.01 93.97 ABADIE D, DURRIEU G, ROUSSIN A, MONTA.. | 10 0.10 94.07 ABDALLA A, RAMLY S, BOERS P, CASSERLY.. | 1 0.01 94.08 ABE Y, ET AL. A CASE OF HYPERINSULINA.. | 1 0.01 94.09 ACIKGOZ SK, ACIKGOZ E. GASTROINTESTIN.. | 1 0.01 94.10 ADAM M, COFFINET C, CORBIERE C, BERTH.. | 2 0.02 94.12 AGOSTI S, CASALINO L, BERTERO G, BURR.. | 1 0.01 94.13 AGRAWAL K, JAIN S, SINGH A. HISTIOCYT.. | 1 0.01 94.14 AL BU ALI WH.. CIPROFLOXACIN-ASSOCIAT.. | 1 0.01 94.15 ALEXANDER J, LEVI L.. INTRACRANIAL HY.. | 1 0.01 94.16 ALLEN-DICKER JW, SUSKIN DA, FESSLER D.. | 1 0.01 94.17 ALVARADO FERNANDEZ M, MARCOS RODRIGUE.. | 1 0.01 94.18 ANNA MITCHELL. ARTERIELLE HYPERTONIE .. | 1 0.01 94.19 ANRI SAWADA. A CASE OF ACUTE NEPHRITI.. | 1 0.01 94.20 AOKI K, OHNUMA T, HOSHIYAMA Y, HAYASH.. | 1 0.01 94.21 AOKI T, KOH K, KOYAMA C, IKEDA Y, KUB.. | 1 0.01 94.22 ARAUJO M, FREITAS D, QUEIROS O. ELECT.. | 1 0.01 94.23 ARKEMA EV, JONSSON J, BAECKLUND E, BR.. | 1 0.01 94.24 ARORA A.. HYPOGLYCAEMIA BEGETS HYPOGL.. | 1 0.01 94.25 ARTUNC F,MUEHLBACHER T,BAUMANN D,BIRS.. | 1 0.01 94.26 ARYAL MR, BADAL M, GIRI S, ARYAL S. H.. | 1 0.01 94.27 ASSI HA, AYOUB ZA, JABER SM, SIBAI HA.. | 1 0.01 94.28 ASSINK MAJ, SPRONK PE, VAN KAN HJM, B.. | 1 0.01 94.29 ASZTELY F, GILLAND E, WATTJES M AND L.. | 1 0.01 94.30 ATIGARI OV, KELLY A-M, JABEEN Q, HEAL.. | 1 0.01 94.31 AUSSERWINKLER M, PLAINER S, NEUMANN H.. | 1 0.01 94.32 AUTHOR UNKNOWN. A SLIDE PRESENTATION.. | 1 0.01 94.33 AZAMA T, YAMAGATA Y, FUKUDA K, AND AZ.. | 1 0.01 94.34 BABACAN, T.. SUNITINIB-INDUCED AUTOIM.. | 1 0.01 94.35 BABAR SM.. SIADH ASSOCIATED WITH CIPR.. | 1 0.01 94.36 BAG,P. A CASE OF AMOEBIC LIVER ABSCES.. | 1 0.01 94.37 BANSAL N, DROSSNER D. CHRONIC PARVOVI.. | 1 0.01 94.38 BANSAL R, SHARMA PK, SHARMA A.. A CAS.. | 1 0.01 94.39 BARBERA N, BUSARDO FP, INDORATO F, RO.. | 5 0.05 94.44 BARETTA Z, FALCI C, PIVA E, CONTE P. .. | 2 0.02 94.46 BARIBEAU D, ARAKI KF.. INTRAVENOUS BU.. | 1 0.01 94.47 BAWANY MZ, BHUTTO B, YOUSSEF WI, NAWR.. | 1 0.01 94.48 BECHADE D, DESOLNEUX G, FONCK M, SOUB.. | 2 0.02 94.50 BELAIZI M, YAHIA A, MEHSSANI J, BOUCH.. | 1 0.01 94.51 BEN AMMAR H, JOMLI R, RIHAB E, MOULA .. | 1 0.01 94.52 BENASSI, F.. ECMO FOR PULMONARY RESCU.. | 1 0.01 94.53 BENDEWALD M, WOOD G.. DOMINANT T-CELL.. | 1 0.01 94.54 BENYOUNES N, ENGRAND N, BARTOLINI B, .. | 1 0.01 94.55 BERKOVICH R AND WEINER L P. EFFECTS .. | 1 0.01 94.56 BESSEMBINDERS KM, BRINKERS JM, VAN DE.. | 2 0.02 94.58 BHARDWAJ N, ISHMAEL FT.. CYTOKINE GEN.. | 1 0.01 94.59 BHAT GM, MIR MH, SHOWKAT HI, KASANNA .. | 2 0.02 94.61 BHAT GM, MIR MH, SHOWKAT HI, KASANNA .. | 1 0.01 94.62 BHAT, SMITA. TNF ALPHA BLOCKADE CAN E.. | 1 0.01 94.63 BIARY R, HOWLAND MA, SMITH SW, HOFFMA.. | 1 0.01 94.64 BIARY R, HOWLAND MA, SMITH SW, HOFFMA.. | 1 0.01 94.65 BIRNS J, HENDERSON K, BHALLA A.. RECR.. | 1 0.01 94.66 BLANCHET PJ. DRUG-INDUCED HYPERKINETI.. | 1 0.01 94.67 BLASCO MORENTE G, TERCEDOR SANCHEZ J,.. | 1 0.01 94.68 BLICHFELDT, L.. SUSPECTED ALLERGIC RE.. | 1 0.01 94.69 BOGLOU P, STEIROPOULOS P, PAPANAS N, .. | 1 0.01 94.70 BOLOGA C, LIONTE C, COMAN A, SORODOC .. | 1 0.01 94.71 BONNER S. ETHICAL DEBATE: ARE ADVANCE.. | 1 0.01 94.72 BORRAS L, EYTAN A, DE TIMARY P, CONST.. | 1 0.01 94.73 BOYER L, GUEDJ E, RICHIERI R, VAILLAN.. | 1 0.01 94.74 BRAUN D, HOROVITZ A, BERTEA M, JENNI .. | 1 0.01 94.75 BRICE P, CHEMINANT M, GALICIER L, BRI.. | 1 0.01 94.76 BRITO JP, SINGH E, BASU A.. IATROGENI.. | 1 0.01 94.77 BROJMOHUN A, LOU JY, ZARDKOOHI O, FUN.. | 1 0.01 94.78 BRUSILOW S , COOPER AJ. ENCEPHALOPATH.. | 1 0.01 94.79 BUCKLIN MH, GORODETSKY RM, WIEGAND TJ.. | 1 0.01 94.80 BURKE MJ, LAMBA J, WEIGEL B, BACHANOV.. | 1 0.01 94.81 BURKE MT, TRNKA P, WALSH M, POOLE L, .. | 1 0.01 94.82 CABANAS, R.. DRESS SYNDROME INDUCED B.. | 1 0.01 94.83 CAFFO O, FRATINO L, RE GL, BASSO U, D.. | 1 0.01 94.84 CAI Z, SHU X, LI J, YANG J. CERVICAL .. | 1 0.01 94.85 CALOGIURI GF, NETTIS E, DI LEO E, VAC.. | 1 0.01 94.86 CANAUD L, HIRECHE K, MARTY-ANE C, ALR.. | 1 0.01 94.87 CARMEN GM, IRENE CO, JESUS JCM, MIGUE.. | 1 0.01 94.88 CAVO M, MASINI L, BLAU IW, HERNANDEZ .. | 1 0.01 94.89 CHALASANI N, FONTANA R.J, BONKOVSKY H.. | 1 0.01 94.90 CHALOUHI C. DRAMATIC EFFECT OF SEQUEN.. | 1 0.01 94.91 CHAN YC, TSE ML, LAU FL. HONG KONG PO.. | 1 0.01 94.92 CHANG R-Y, LEE M-Y, KAN C-B, HSU W-P,.. | 1 0.01 94.93 CHAUDHRY F.. ADVERSE REACTION TO NEXP.. | 1 0.01 94.94 CHEN S-N, LIN C-J, LI K-H, HWANG J-F... | 1 0.01 94.95 CHOPRA A, SELIM B, SILBER MH, KRAHN L.. | 1 0.01 94.96 CHOY E, BALASUBRAMANIAN S, BUTRYNSKI .. | 1 0.01 94.97 COLON B, HORTA JM, CASILLAS S, BERTOL.. | 1 0.01 94.98 COOL RM, GULBIS AM. RHABDOMYOLYSIS AF.. | 1 0.01 94.99 COPPES O, LUKAS R, FLEMING G, NICHOLS.. | 1 0.01 95.00 CORLISS RF, MANDAL R, SORIANO BJ.. BI.. | 1 0.01 95.01 COUTINHO, R. HIV STATUS DOES NOT IMPA.. | 1 0.01 95.02 COUTINHO, R.. HIV STATUS DOES NOT IMP.. | 1 0.01 95.03 CREMONA F, TOSTO C, AGNELLO G. IDIOPA.. | 1 0.01 95.04 DABROWSKI M. PANCREATIC CANCER IN TYP.. | 1 0.01 95.05 DAISUKE NAKANISHI. ADVERSE EVENT MONI.. | 1 0.01 95.06 DANIELS BH, MCCOMB RD, MOBLEY BC, GUL.. | 2 0.02 95.08 DARLING A, ARGUELLES PP, PEREZ-DUENAS.. | 1 0.01 95.09 DAS S, MONDAL S, DEY JK, BANDYOPADHYA.. | 1 0.01 95.10 DAVIES G, WILSON H, WILHELM T, BOWLER.. | 1 0.01 95.11 DAVIS JJ, BUCK NS, SWENSON JD, JOHNSO.. | 1 0.01 95.12 DE WINTER S, MEERSSEMAN W, VERELST S,.. | 1 0.01 95.13 DEEB W, IZZY S, HAMEED B, MUEHLSCHLEG.. | 1 0.01 95.14 DEHGHANI A, ABTAHIA M, ABTAHIA S, PEY.. | 1 0.01 95.15 DEPREZ FC, COLIN GC, HAINAUT P.. SPON.. | 1 0.01 95.16 DESAI NN, CHERKAS DS, KIM HK, SMITH S.. | 1 0.01 95.17 DETTINO ALA, MOLIN GZD, NICOLAU UR, L.. | 1 0.01 95.18 DICKERSON EM, JONES P, WILKINS D, REG.. | 1 0.01 95.19 DIGBY, G. C.. ACQUIRED LONG QT INTERV.. | 1 0.01 95.20 DJAOUAD BK, SALIM A. CASES OF PML IN.. | 1 0.01 95.21 DONINI M, BUTI S, LAZZARELLI S, BOZZE.. | 1 0.01 95.22 DOUROS A, BRONDER E, ANDERSOHN F, KL.. | 1 0.01 95.23 DRAZ N, DATTA S, WEBSTER DP, CROPLEY .. | 1 0.01 95.24 DU W, LEHR VT, LIEH-LAI M, KOO W, WAR.. | 1 0.01 95.25 DUFFULL SB, ISBISTER GK. PREDICTING T.. | 1 0.01 95.26 EEFTINCK SCHATTENKERK JKM, LAGER PS.... | 1 0.01 95.27 EHARA D, ETAL ERYTHEMA MULTIFORME: CA.. | 1 0.01 95.28 EJIMA T.. RECTUS SHEATH HAEMATOMA IN .. | 1 0.01 95.29 ENZENSBERGER C, ESKEF K, SCHWARZE A, .. | 1 0.01 95.30 ENZENSBERGER C, ESKEF K, SCHWARZE A, .. | 1 0.01 95.31 ERCAN S, ALTUNBAS G, OYLUMLU M, SUCU .. | 1 0.01 95.32 ERTURAN I, YUKSEL BASAK P.. A CASE OF.. | 1 0.01 95.33 ESLAMI SHAHRBABAKI M, ESTILAEE F, MEH.. | 1 0.01 95.34 EVENS AM, CARSON KR, KOLESAR J, NABHA.. | 1 0.01 95.35 FAKILI F, METE T, COLAK D.. A CASE OF.. | 1 0.01 95.36 FEDER, H. M.. CHLORAMPHENICOL: A REVI.. | 3 0.03 95.39 FELLMAN M, CARTER K, CALL CB, ESMAELI.. | 1 0.01 95.40 FERACOTTA S ET AL.. LONG TERM FOLLOW-.. | 1 0.01 95.41 FERGUSON NN, ASARCH A, VANBEEK M, SWI.. | 1 0.01 95.42 FERRANDINA G, DISTEFANO MG, DE VINCEN.. | 1 0.01 95.43 FERRARI B, FOGAZZI GB, GARIGALI G, ME.. | 1 0.01 95.44 FETTEROLF F, MARCEAU M.. A CASE OF BU.. | 1 0.01 95.45 FINKELMAN, I. UNTOWARD EFFECTS OF PHE.. | 1 0.01 95.46 FINKELMAN, I. UNTOWARD EFFECTS OF PHE.. | 1 0.01 95.47 FINKELMAN,I. UNTOWARD EFFECTS OF PHEN.. | 2 0.02 95.49 FOSS FM, SJAK-SHIE N, GOY A, JACOBSEN.. | 1 0.01 95.50 FRANCES ARTIGAS C, NICOLAU RAMIS J, R.. | 1 0.01 95.51 FRANCES L, GUIJARRO J, MARIN I, LEIVA.. | 1 0.01 95.52 FRIDER B, BUONSANTE ME, TISCORNIA J, .. | 1 0.01 95.53 FUJITA T, TANABE M, IIDA E, OKIMOTO T.. | 1 0.01 95.54 FUJIWARA Y, CHAYAHARA N, MUKOHARA T, .. | 2 0.02 95.56 GALLAGHER, J. ANAPHYLAXIS IN PREGNANC.. | 1 0.01 95.57 GALLO E, MAGGINI V, BERARDI M, PUGI A.. | 1 0.01 95.58 GARCIA M, RUIZ B, AGUIRRE C, ETXEGARA.. | 1 0.01 95.59 GATTRINGER T, ENZINGER C, KHALIL M, S.. | 1 0.01 95.60 GEORGOULIDOU A, MPAKALOUDIS A, EXIARA.. | 1 0.01 95.61 GERALDO DJ, CHAMBEL M, SOUSA F, PRATE.. | 1 0.01 95.62 GIBO H,KAWABE S. ONE CASE OF TYPE 2 D.. | 1 0.01 95.63 GIORDANO D, PANINI A, PERNICE C, RASO.. | 1 0.01 95.64 GLUHOVSCHI G, GLUHOVSCHI C, VELCIOV S.. | 1 0.01 95.65 GLUHOVSCHI G, GLUHOVSCHI C, VELCIOV S.. | 1 0.01 95.66 GONZALEZ RAMOS J, ALONSO PACHECO M, M.. | 1 0.01 95.67 GONZVA J, PRUNET B, DENIEL C, BENNER .. | 1 0.01 95.68 GOSALA S, VIKRAM K, THOMAS M, AJIT RK.. | 1 0.01 95.69 GOTO M. MASSIVE MELENA AFTER AUTOLOGO.. | 1 0.01 95.70 GRANGER K, NINAN S, STOPFORD E. THE P.. | 1 0.01 95.71 GRIECO A ET AL. SEVERE CHOLESTATIC HE.. | 1 0.01 95.72 GUERCI P, VIAL F, RAFT J, NELIS UM, M.. | 1 0.01 95.73 GUYMER C, KHURANA S, SUPPIAH R, HENNE.. | 1 0.01 95.74 HADANO Y, OGAWA H, WAKEYAMA T, IWAMI .. | 1 0.01 95.75 HAGIYA H, MIYAKE T, KOKUMAI Y, MURASE.. | 1 0.01 95.76 HAM JC, RUIJS GJHM, VAN MARWIJK KOOY .. | 1 0.01 95.77 HAM JC, RUIJS GJHM, VAN MARWIJK KOOY .. | 1 0.01 95.78 HAMANO H, MOTOMIYA M, IWASAKI N.. ADV.. | 1 0.01 95.79 HAMASAKI H, HIRAISHI C, YANAI H.. SEV.. | 1 0.01 95.80 HAMDI W, GHANNOUCHI MM, KAFFEL D, KCH.. | 1 0.01 95.81 HAMMERNESS P, GEORGIOPOULOS A, DOYLE .. | 1 0.01 95.82 HANNA J, BEE J, SATALOFF RT.. LARYNGE.. | 1 0.01 95.83 HARMANCI H, TAYCAN SE, CELIKEL FC, UN.. | 1 0.01 95.84 HASHIMOTO T, YOKOYAMA M, KIMURA S, US.. | 1 0.01 95.85 HASHIYADA M, USUI K, HAYASHIZAKI Y, H.. | 1 0.01 95.86 HASIJA RP, SILVERMAN ED, CHO S, FUNG .. | 1 0.01 95.87 HASIJA RP, SILVERMAN ED, CHO S, FUNG .. | 1 0.01 95.88 HATA A, KATAKAMI N, FUJITA S, TAKATOR.. | 2 0.02 95.90 HATTEN K, LOEVNER L, PALMER J.. ISOLA.. | 1 0.01 95.91 HAWTON K, BERGEN H, SIMKIN S, DODD S,.. | 1 0.01 95.92 HEARD KJ, GREEN JL, RHYEE S, DART RC... | 1 0.01 95.93 HELLFRITZSCH M, LASSEN P, NIELSEN LP... | 1 0.01 95.94 HERNANDEZ MV, PERIS P, MONEGAL A, REY.. | 1 0.01 95.95 HEROLD M. BIOREG: SUCCESSFUL BIOLOGIC.. | 1 0.01 95.96 HEROLD M. BIOREG: SUCCESSFUL BIOLOGIC.. | 5 0.05 96.01 HERSHKO H.. A CASE OF A PREVENTABLE D.. | 1 0.01 96.02 HERZBERG G. OUTCOMES AFTER BILATERAL .. | 1 0.01 96.03 HESS, G.. SAFETY AND EFFICACY OF TEMS.. | 1 0.01 96.04 HIDALGO CP,HERNANDEZ LA, CRIADO IMT, .. | 1 0.01 96.05 HIDEFUMI HIRAMATSU. PROLONGED SEVERE .. | 1 0.01 96.06 HILLEN ME, COOK SD, SAMANTA A, GRANT .. | 1 0.01 96.07 HIRAKAWA T. A CASE OF MALIGNANT TONGU.. | 1 0.01 96.08 HIRATA I, KIMIZU T, IKEDA T, KIMURA S.. | 1 0.01 96.09 HIROSAWA T,HAYASHI H,SAKATA N,ISHIDA .. | 1 0.01 96.10 HOEPNER R, AHLBRECHT J, FAISSNER S, S.. | 1 0.01 96.11 HOLUBEC L, MRAZKOVA P, MATEJKA VM, FI.. | 2 0.02 96.13 HONDA M, KUWATSUKA Y, YOSHIMA K, ET A.. | 1 0.01 96.14 HOSOKAWA, KOHEI. PULMONARY VENO-OCCLU.. | 1 0.01 96.15 HSU S-T, WANG R-C, LU C-H, KE Y-M, CH.. | 1 0.01 96.16 HUEMER M, SARGANAS G, BRONDER E, KLIM.. | 1 0.01 96.17 HUERTA LJG ET AL.. TRIMETHOPRIM-SULFA.. | 1 0.01 96.18 HURVITZ SA, HEGDE P, BOSSERMAN L, ALL.. | 1 0.01 96.19 IGETA H, SUZUKI Y, MOTEGI T, SASAKI A.. | 1 0.01 96.20 IMAI H, SATO N, IIDA T, KACHI M, MIKU.. | 1 0.01 96.21 IMAMURA T, KINUGAWA K, KATO N, MINATS.. | 1 0.01 96.22 ISEDA I, HIDA K, TONE A, TENTA M, SHI.. | 1 0.01 96.23 ISHIKAWA T, SHIMIZU D, KITO A, OTA I,.. | 1 0.01 96.24 ISHIMOTO T, FUKUDA Y, ISHIKAWA T, FUD.. | 1 0.01 96.25 ITO S. OPTIMAL CONDITIONS OF THE TREA.. | 1 0.01 96.26 ITO, HOSHINO Y, ITO H, MASUGI Y, TERA.. | 1 0.01 96.27 IWAKI N, NINOMIYA KIICHI AKIRA, ICHIH.. | 1 0.01 96.28 J.A. HUNTER. ACUTE PSYCHOSIS IN THREE.. | 1 0.01 96.29 JACOB A, FUMERY M, SALLERON J, MICHAU.. | 1 0.01 96.30 JAIN M. POST-TRANSPLANT LYMPHOPROLIFE.. | 1 0.01 96.31 JAIN M. POSTTRANSPLANT LYMPHOPROLIFER.. | 1 0.01 96.32 JAIN M. POSTTRANSPLANT LYMPHOPROLIFER.. | 1 0.01 96.33 JAKES AD, JANI P, BHANDARI S. CASE RE.. | 1 0.01 96.34 JENSEN K, STEINTHORSDOTTIR KJ, BRANDT.. | 1 0.01 96.35 JOHN SPERATI C.. STABILIZATION OF HEP.. | 1 0.01 96.36 JOOSTEN H, DRION I, BOOGERD KJ, VAN D.. | 1 0.01 96.37 JORDAENS L, DE PAUW M AND CAES F.. FA.. | 1 0.01 96.38 JOSEPH R, BOCKORNY B, DASANU CA.. MET.. | 1 0.01 96.39 JOSOL CV, BUENALUZ-SEDURANTE M, SANDO.. | 1 0.01 96.40 JUNAID I, KLAUSTERMEYER WB. A CASE OF.. | 1 0.01 96.41 KABATA, YOSHIAKI. CYTOMEGALOVIRUS RET.. | 1 0.01 96.42 KADAM PG, JAYAPRAKASH, SHAH VR.. POST.. | 1 0.01 96.43 KADOTA T, SHIMIZU K, TSURUSHIGE C, KA.. | 1 0.01 96.44 KAFADAR I, MOUSTAFA F, YALCIN K, KILI.. | 1 0.01 96.45 KAKAVAS S, BALIS E, LAZAROU V, KOUVEL.. | 1 0.01 96.46 KALKUR P,KREZE O,CHAUHAN N,LIM S,ANTO.. | 1 0.01 96.47 KAMEI K, OKADA M, MIYAZONO A AND SATO.. | 1 0.01 96.48 KAMIMURA Y,AOYAMA A,TOYODA M,BOKURA H.. | 2 0.02 96.50 KANAKIS G., KALTSAS G., GRANBERG D., .. | 1 0.01 96.51 KANE A, MITCHELL SJ, CARROLL PR, MATT.. | 1 0.01 96.52 KANG GH, MOON HS, LEE ES, KIM SH, LEE.. | 1 0.01 96.53 KAPLAN HG, MALMGREN JA, ATWOOD MK. MY.. | 1 0.01 96.54 KAR R, DHINGRA B, VIBHA D, MAHAPATRA .. | 1 0.01 96.55 KARABAG T, AYDIN M, DOGAN SM. A RARE .. | 1 0.01 96.56 KARADAG R, ESMER O, SOYLU E, ONER AF,.. | 1 0.01 96.57 KATE N, GROVER S, KUMAR S, MODI M. BU.. | 1 0.01 96.58 KATIMAN D, MANIKAM J, GOH K-L, ABDULL.. | 1 0.01 96.59 KATO I, SATO S, KASAL F, WATANABE H, .. | 1 0.01 96.60 KAWACHI I, YOKOSEKI A, SAJI E, ARAKAW.. | 1 0.01 96.61 KAWASHIMA J, NAOE H, SASAKI Y, ARAKI .. | 1 0.01 96.62 KELLER GA, PONTE ML, DIEZ RA, DI GIRO.. | 1 0.01 96.63 KEMPENEERS D, GIELEN K, LUCKER G.. RH.. | 1 0.01 96.64 KHUBCHANDANI SR, BICHLE LS.. HYDROXYC.. | 1 0.01 96.65 KIKUCHI T, KATO M, TAKAHASHI N, NAKAM.. | 1 0.01 96.66 KIM DJ, KIM J, SPAUNHURST K, MONTOYA .. | 1 0.01 96.67 KIM H-J, AN SH, CHO YH, KIM S-Y, LEE .. | 1 0.01 96.68 KING AM, PUGH JL, MENKE NB, KRASOWSKI.. | 2 0.02 96.70 KIVISTO K., ALAPULLI H., TUPOLA S., A.. | 1 0.01 96.71 KIVISTO, K., ALAPULLI, H., TUPOLA, S... | 1 0.01 96.72 KOBAYASHI T, MASAKI T, KOGAWA K, MATS.. | 1 0.01 96.73 KOBAYASHI Y, YAMADA R, YAMAMOTO T, SU.. | 1 0.01 96.74 KOBAYASHI YUKA. A CASE OF PANCREAS NE.. | 1 0.01 96.75 KOCAK AY, KOCAK O, ASLAN F, TEKTAS M... | 1 0.01 96.76 KOHASHI S, MORI T, KATO J, KIKUCHI T,.. | 1 0.01 96.77 KONDO N. 1-PO-334: CLINICAL PRESENTAT.. | 1 0.01 96.78 KONO M, KAWAKAMI T, HAMASAKI Y, SHOTA.. | 1 0.01 96.79 KOSMAS C, PAPACHRYSANTHOU T, DALADIMO.. | 1 0.01 96.80 KOUDELKOV? M, SZABOV? Z, HAVRDOV? E, .. | 1 0.01 96.81 KOWALZICK L, EICKENSCHEIDT L. OCCURRE.. | 1 0.01 96.82 KRUEGER K, KRUEGER P, LEHMANN H. THRE.. | 1 0.01 96.83 KRYSIAK R, OKOPIEN B. DRUG-INDUCED EX.. | 1 0.01 96.84 KULEVA SA.. DELAYED ELIMINATION OF ME.. | 1 0.01 96.85 KUMAR KA, SACHDEV A, CHINNABHANDAR V,.. | 1 0.01 96.86 KURAHARA K, OSHIRO Y, OKAMOTO Y, KAWA.. | 1 0.01 96.87 KURIAN MA, DEJEU E, GAUTHEY M, SOROKE.. | 1 0.01 96.88 KUSUKAWA N, ISHIDA H, TANASE K, ITO H.. | 1 0.01 96.89 L ZULLIG, K SCHNYXDER, SIMON STAUBLE... | 1 0.01 96.90 LALITHA R, OPIO CK. A MISSED DIAGNOSI.. | 1 0.01 96.91 LARA R, WAINSTEIN E, GUZMAN L. TENOSY.. | 1 0.01 96.92 LAWRENCE I, LEAR J, BURDEN A, MADDOCK.. | 1 0.01 96.93 LAZARO PCF, LOUREIRO JC, BANZATO CEM... | 1 0.01 96.94 LEE A, VAZQUEZ R. VENOUS GAS EMBOLISM.. | 2 0.02 96.96 LEGRAND M, PAYEN D.. CASE SCENARIO: H.. | 1 0.01 96.97 LERTXUNDI U, ISLA RUIZ A, SOLINIS ASP.. | 1 0.01 96.98 LERTXUNDI U, PALACIOS RH, GUTIERREZ F.. | 1 0.01 96.99 LERTXUNDI U, RUIZ AI, SOLINIS ASPIAZU.. | 1 0.01 97.00 LESCOAT A, POINSIGNON Y, DOS SANTOS A.. | 1 0.01 97.01 LESLIE ABRAMSON. NOVEL METHOD TO COLL.. | 1 0.01 97.02 LESLIE SD.. SOTALOL-ASSOCIATED CARDIO.. | 1 0.01 97.03 LEV-RAN S, LE FOLL B, ARAKI KF. A CAS.. | 1 0.01 97.04 LEVI N, BASTUJI-GARIN S, MOCKENHAUPT .. | 1 0.01 97.05 LI M, HOSCHAR AP, BUDD GT, CHAO ST, S.. | 1 0.01 97.06 LI. HEPATOTOXICITY DUE TO ETANERCEPT .. | 1 0.01 97.07 LIANG Y, GUAN J-Z, LI N.. DIAGNOSIS A.. | 2 0.02 97.09 LIN C-H, LIU C-M, HUANG W-L.. QUETIAP.. | 1 0.01 97.10 LIN P-Y, PENG L-Y, LEE Y.. ELECTROCON.. | 1 0.01 97.11 LINTNER CP, TOPEFF JM, KATZUNG KG, KW.. | 3 0.03 97.14 LLAMAS-VELASCO M, GODOY A, SANCHEZ-PE.. | 1 0.01 97.15 LOSEKAM S, KLUGE I, NITTEL KS, KIRCHE.. | 1 0.01 97.16 LOTFOLLAHI L, TABARSI P, AHMAD NASSIR.. | 1 0.01 97.17 LOURENCO-MATHARU L, RAVAL P. AN UNUSU.. | 1 0.01 97.18 LUNG DD, WU AHB, GERONA RR.. CARDIOTO.. | 1 0.01 97.19 M KOWALCZYK, P G RUBINSTEIN, D M ABOU.. | 1 0.01 97.20 M RA. HYPERPROLACTINEMIA AND ATYPICAL.. | 1 0.01 97.21 M T COLLINS, A M BOYCE, W H CHONG ET .. | 1 0.01 97.22 M. CARPENEDO, S. CANTONI, V. COCCINI .. | 1 0.01 97.23 MACDONALD K, NORMAN WV, POPESCU O.. N.. | 1 0.01 97.24 MADADI, P.. LIFE-THREATENING ADVERSE .. | 1 0.01 97.25 MAEBA H, NISHIMURA Y, UMASE S, FUJIKI.. | 1 0.01 97.26 MAEHARA S, ET AL.. BRIEF REPORT: A CA.. | 1 0.01 97.27 MAGALHAES RK, FERREIRA D, SALGADO M, .. | 1 0.01 97.28 MAH L, HART M.. GABAPENTIN WITHDRAWAL.. | 2 0.02 97.30 MAKABE S, OKANO K, TSUKADA M, TSUCHIY.. | 1 0.01 97.31 MALAIYANDI D, PANDYA D, ABRAHAM M, TA.. | 1 0.01 97.32 MANCHANDA A, CAMERON C, ROBINSON G. B.. | 1 0.01 97.33 MANIKA K, TASIOPOULOU K, VLOGIARIS L,.. | 1 0.01 97.34 MANJUNATHA N, GANJEKAR S, MAHENDRA JV.. | 1 0.01 97.35 MANNOCCHI G, NAPOLEONI F, NAPOLETANO .. | 1 0.01 97.36 MARAS H, IPEKCI B, YOLOGLU N, AYDOGAN.. | 1 0.01 97.37 MARCK B, MARTINA R, ZVENDANA H, NINA .. | 1 0.01 97.38 MARGARITOPOULOU I, MANIKA I, GOUSI G... | 1 0.01 97.39 MARTIN TL, WOODALL KL, MCLELLAN BA. F.. | 1 0.01 97.40 MARTIN-HUYGHE H, BOURNEAU-MARTIN D, B.. | 1 0.01 97.41 MATSUO K, NAMBU T, MATSUDA Y, KANAI Y.. | 1 0.01 97.42 MATSUYOSHI T,SASAKI N,YAMAGUCHI K,KOJ.. | 1 0.01 97.43 MATSUZAKI T, OHKUBO K, YUKI M, KAWASH.. | 1 0.01 97.44 MATTOO SK, MAHAJAN S, SARKAR S, NEBHI.. | 1 0.01 97.45 MAUGHAN C, LEAR W.. ACUTE ANGIOEDEMA .. | 1 0.01 97.46 MEANEY C, SAREH H, HAYES B, GONZALES .. | 1 0.01 97.47 MELLADO E, DE LA CAMARA R, BUENDIA B,.. | 1 0.01 97.48 MELLON G, STITOU H, AOUN O, TUBIANA R.. | 1 0.01 97.49 MESAR I, KES P, HUDOLIN T, BASIC-JUKI.. | 1 0.01 97.50 MESSINA, M.. PULMONARY SYNERGISTIC TO.. | 1 0.01 97.51 MI, E.. A 31-YEAR-OLD PATIENT WITH DR.. | 1 0.01 97.52 MILOSEVIC D, MISE B, HABUS I, TOPALOV.. | 1 0.01 97.53 MIRZAKHANI H, NOZARI A, EHRENFELD JM,.. | 1 0.01 97.54 MIXON BA, ECKRICH MJ, LOWAS S, ENGEL .. | 1 0.01 97.55 MOHANDAS A, BHUWAN ROY B, SAPARA A.. .. | 1 0.01 97.56 MOHYUDDIN GR, AL ASAD M, SCRATCHKO L,.. | 1 0.01 97.57 MORGAN BICKNELL LT, SANCHES M, SCHATT.. | 1 0.01 97.58 MORI N, TANIGUCHI H. A CASE OF PROLON.. | 1 0.01 97.59 MOSEL D, HARRIS L, FISHER E, OLASZ E,.. | 1 0.01 97.60 MOYANO C, BELDJERD M, PECOURNEAU V, B.. | 1 0.01 97.61 MOYANO C.. INFECTION OF THE SIGMOID C.. | 1 0.01 97.62 MOYANO C.. INFECTION OF THE SIGMOID C.. | 1 0.01 97.63 MOYANO, C. COLITE INFECTIEUSE, UNE CO.. | 1 0.01 97.64 MRVOS R, PUMMER TL, KRENZELOK EP.. AM.. | 4 0.04 97.68 MUHAMAD N, AZIZAN M, MASANI N, LING T.. | 1 0.01 97.69 MUNIGOTI S, FRAZER R, REES A, BLACKSH.. | 1 0.01 97.70 NAFIL H, TAZI I, MAHMAL L. PARAPLEGIA.. | 1 0.01 97.71 NAGASE D. A CASE OF A PATIENT WITH CH.. | 1 0.01 97.72 NAKAGAWA, T. ARGATROBAN CAUSED SEVERE.. | 1 0.01 97.73 NAKAMURA J, NAGASHIMA T, YOSHIO T, .. | 1 0.01 97.74 NAKAYAMA N, SATO A, TANAKA S, SHIMADA.. | 1 0.01 97.75 NARAYANAN D, KILPATRICK ES.. ATORVAST.. | 1 0.01 97.76 NARDONE B, WEST DP, RAISCH DW, ABRAMO.. | 1 0.01 97.77 NASCIMENTO M, GRACA J, PALMA D, TRANC.. | 1 0.01 97.78 NEROUTSOS E, ROUPAKA A, FISTE M, VAGI.. | 1 0.01 97.79 NIMBALKAR SM, PATEL DV.. NEAR FATAL C.. | 1 0.01 97.80 NISCOLA, P.. ATYPICAL MYELODYSPLASTIC.. | 1 0.01 97.81 NISHI T, HARADA J, SUGIMOTO K, IWATA .. | 1 0.01 97.82 NISHIMURA T, YAMAGUCHI K, MORIGUCHI M.. | 1 0.01 97.83 NISHIO S, TSUBOI N, KURASHIGE M, TANA.. | 1 0.01 97.84 NOMURA N. TWO CASES OF SARCOIDOSIS IN.. | 1 0.01 97.85 NOWOTNIK J, RENTSCH D, BITTORF A, LIN.. | 1 0.01 97.86 OFFIDANI M, CORVATTA L, POLLONI C, GE.. | 1 0.01 97.87 OGLODEK E, SZOTA A, ARASZKIEWICZ A.. .. | 1 0.01 97.88 OHASHI Y, TERUI K, TAMURA K, TANAKA M.. | 5 0.05 97.93 OHE M, HASHINO S. SUCCESSFUL TREATMEN.. | 1 0.01 97.94 OHE M, HASHINO S.. SUCCESSFUL TREATME.. | 1 0.01 97.95 OKADA R, INOKUMA S, MIURA Y, KOBUNA M.. | 1 0.01 97.96 OKAJIMA R. A CASE OF DRUG- INDUCED LI.. | 1 0.01 97.97 OKI Y, WESTIN JR, VEGA F, CHUANG H, F.. | 1 0.01 97.98 OMULECKI A, OLEJNICZAK-STARUCH I, TOR.. | 1 0.01 97.99 ONO S, SUZUKI Y, SOMEYA T.. PROLONGAT.. | 1 0.01 98.00 ONODA N, KAWAJIRI H, KASHIWAGI S, NAK.. | 1 0.01 98.01 OSHIRO H, GOI K, AKAHANE K, INUKAI T,.. | 1 0.01 98.02 OSTERHOUDT KC, TRELLA J, HENRETIG F. .. | 1 0.01 98.03 OUANES S, ABDELGHAFFAR W, RAFRAFI R, .. | 1 0.01 98.04 OZCAN E E, SZEPLAKI G, OSZTHEIMER I, .. | 1 0.01 98.05 P. BRICE, M. CHEMINANT, L. GALICIER, .. | 1 0.01 98.06 P. ZAFEIROPOULOS ET AL. EP05. BILATER.. | 1 0.01 98.07 PALERMO-GAROFALO C, MARTINEZ JH, SILV.. | 1 0.01 98.08 PALICKOVA M, MOCIKOVA H, VERNEROVA Z,.. | 1 0.01 98.09 PALMA M, MARTINS M, ALVES R, LUIS A, .. | 1 0.01 98.10 PANDEJPONG D, SAENGSURI P, RATTARITTA.. | 1 0.01 98.11 PAPANIKOLAOU X, SZYMONIFKA J, ROSENTH.. | 3 0.03 98.14 PARADIS CM, SIEGEL LA, KLEINMAN SB.. .. | 1 0.01 98.15 PARADIS CM, SIEGEL LA, KLEINMAN SB.. .. | 1 0.01 98.16 PARAKKAL D, DERRICK S, ELI E. ANALYSI.. | 1 0.01 98.17 PARKER SD, GIOANNIS AD, PAGE C. CHRON.. | 1 0.01 98.18 PATRA S, VIJ M, SUKANYA B, KAPOOR D. .. | 1 0.01 98.19 PAUL G, TERRANOVA LM, ALIGENE K, FINE.. | 1 0.01 98.20 PAUTOLA L, REINIKAINEN M. INTERACTION.. | 1 0.01 98.21 PEARCE B, GRANT IS. ACUTE LIVER FAILU.. | 1 0.01 98.22 PELLEGRINO P, CARNOVALE C, BORSADOLI .. | 1 0.01 98.23 PENCHARZ D, QUIGLEY A-M, HALL M, WAGN.. | 1 0.01 98.24 PEREZ ROBLES T, RUANO ENCINAR M, CABA.. | 1 0.01 98.25 PETERSEN AB, ANDERSEN SE, CHRISTENSEN.. | 1 0.01 98.26 PINA Y, BOUTRID H, MURRAY TG, WOLFE S.. | 1 0.01 98.27 PINA Y, BOUTRID H, MURRAY TG, WOLFE S.. | 1 0.01 98.28 PLESINAC S, BABOVIC I, PLESINAC KARAP.. | 1 0.01 98.29 PLESINAC S, BABOVIC I, PLESINAC KARAP.. | 1 0.01 98.30 PLIMACK ER, HOFFMAN-CENSITS JH, VITER.. | 1 0.01 98.31 POCSAY ET AL.. HASHIMOTO-ENCEPHALOPAT.. | 1 0.01 98.32 POUSSEL M, VAUTHIER J-C, RENAUD P, GA.. | 1 0.01 98.33 POUSSEL M, VAUTHIER JC, RENAUD P, GAM.. | 1 0.01 98.34 PRESCOTT LF. THERAPEUTIC MISADVENTURE.. | 1 0.01 98.35 PRESCOTT LF. THERAPEUTIC MISADVENTURE.. | 1 0.01 98.36 PRIETO PERAITA M, SANCHEZ MARCOS MJ, .. | 1 0.01 98.37 PRIETO PERAITA M, SANCHEZ MARCOS MJ, .. | 1 0.01 98.38 PROENCA P, FRANCO JM, MUSTRA C, MONTE.. | 1 0.01 98.39 PROUDFOOT M, GORMLEY J.. SEROTONIN SY.. | 1 0.01 98.40 PSAILA M, FSADNI P, MONTEFORT S. CHRO.. | 1 0.01 98.41 PUNNAM SR, POTHULA VR, GOURINENI N, P.. | 1 0.01 98.42 PUOLITAIVAL A, KONONOFF A AND KAIPIAI.. | 1 0.01 98.43 PUOLITAIVAL A, KONONOFF A AND KAIPIAI.. | 1 0.01 98.44 PURROY N, BERGUA J, GALLUR L, PRIETO .. | 1 0.01 98.45 QADIR H, VASUDEVA A, SCHMIDT R.. VANC.. | 1 0.01 98.46 RAM R, SWARNALATHA G, RAMESH V, NAGES.. | 1 0.01 98.47 RANGNEKAR AS, ELLERBE C, DURKALSKI V,.. | 1 0.01 98.48 RASMUSSEN L,VIBERG B,POTTEGARD A. FAT.. | 1 0.01 98.49 RAY M, CURTIS J, BADDLEY J. A CASE RE.. | 1 0.01 98.50 RAYNER SG, HOSSEINI F, ADEDIPE AA.. S.. | 1 0.01 98.51 REA C, BEVAN D, SORENSEN B. [P-TU-504.. | 1 0.01 98.52 REDDY S, SARAYU P, SRIKANTH MS, ADEPU.. | 1 0.01 98.53 REPORTER KNOWN TO THE AUTHORITY, DOMI.. | 1 0.01 98.54 REVERDY F, FREICHET M, GROZEL JM, TAS.. | 1 0.01 98.55 RICHARD S, IDRISSI AL, JONAS J, VUILL.. | 1 0.01 98.56 RODRIGUES R, AMADOR P, RASSI L, SEIXO.. | 1 0.01 98.57 RODRIGUEZ DA, BUSTACARA M, PINILLA AP.. | 1 0.01 98.58 ROGOSNITZKY M, FINEGOLD MJ, MCLAUGHLI.. | 1 0.01 98.59 ROLMA G, JELCIC N, GNOATO F, CECCHIN .. | 1 0.01 98.60 ROMANO A, GAETA F, VALLUZZI RL, CARUS.. | 1 0.01 98.61 ROWBOTTOM L, MOLE T, ROBERTS N.. UNEX.. | 1 0.01 98.62 ROZANSKI J, KEDZIERSKA K. GOLEMBIEWSK.. | 1 0.01 98.63 ROZATI H, SHAH SP, PENG YY. LOWER LIM.. | 1 0.01 98.64 RUDRAPATNA VK, MORLEY K, BOUCHER KM, .. | 1 0.01 98.65 RUI, P. A 50-YEAR-OLD MAN WITH FEVER,.. | 1 0.01 98.66 RUISZ W, STOLLBERGER C, FINSTERER J, .. | 1 0.01 98.67 RUIZ SALAS V, PUIG L, ALOMAR A. USTEK.. | 4 0.04 98.71 RUMACK BH. ACETAMINOPHEN OVERDOSE IN.. | 1 0.01 98.72 RUSSO A, MIRANI A, PERLMAN J, MILLER .. | 1 0.01 98.73 RYU M-H, YOO C, KIN JG, RYOO B-Y, PAR.. | 1 0.01 98.74 SABA NS, DANG D, SABA J, CAO C, JANBA.. | 1 0.01 98.75 SAENG-ANAN U, SRESHTHAPUTRA O, SUKPAN.. | 1 0.01 98.76 SAFAA L, LOUBNA E, HACHMIA AB, WAFAA .. | 1 0.01 98.77 SAHMELIKOGLU O, MANER AF, KIZILKALE H.. | 1 0.01 98.78 SAID S, COOPER CJ, ALKHATEEB H, ELHAN.. | 1 0.01 98.79 SAITO F, HATANO T, HORI M, KAWAMURA M.. | 1 0.01 98.80 SAKAMOTO R,KIYOKAWA K,MOTOKI Y,ASARI .. | 1 0.01 98.81 SALAZAR R, DUBOW J. DELAYED POSTHYPOX.. | 1 0.01 98.82 SALGUEIRO P, LAGO P, PEDROTO I.. DIAG.. | 1 0.01 98.83 SALGUEIRO P, LAGO P, PEDROTO I.. DIAG.. | 1 0.01 98.84 SALOUAGE I, SASSI MB, GAIES E, CHARFI.. | 1 0.01 98.85 SANAEI-ZADEH H.. TRAMADOL INTOXICATIO.. | 1 0.01 98.86 SARKAR S, MONDAL R, NANDI M, DAS AK. .. | 1 0.01 98.87 SATO H, ITO S, NAGAI S, MURASAWA A, W.. | 1 0.01 98.88 SATOSHI I. OPTIMAL CONDITIONS OF THE .. | 1 0.01 98.89 SAVARD M, DUPRE N, TURGEON A, ET AL. .. | 1 0.01 98.90 SAVARY LA, CHAVANT F, LAFAY-CHEBASSIE.. | 1 0.01 98.91 SAWANT RD. RHABDOMYOLYSIS DUE TO AN U.. | 1 0.01 98.92 SAXENA R, MARAIS G. SALBUTAMOL: BEWAR.. | 1 0.01 98.93 SCHAEFER IM, MARX A, SAUER C, HOHLOCH.. | 1 0.01 98.94 SCHELL AM, PETRAS M, SZCZEPIORKOWSKI .. | 1 0.01 98.95 SCHMITT C,KERVEGANT M,AJALTOUNI Z,TAU.. | 1 0.01 98.96 SCHOLL, J. SIX CASES OF (SEVERE) HYPO.. | 1 0.01 98.97 SCHOLTEN HJ, NAP A, BOUWMAN RA, BIERM.. | 1 0.01 98.98 SCHULMAN S,CARRIER M,LEE A,SHIVAKUMAR.. | 1 0.01 98.99 SCIENCE M, ITO S, KITAI I.. ISONIAZID.. | 1 0.01 99.00 SEMINERIO JL, LOFTUS EJ, COLOMBEL J, .. | 1 0.01 99.01 SEYMOUR N, PATEL T, DIXON H.. WORSENI.. | 1 0.01 99.02 SHAH N, OWEN L, BHAGANI S.. ^OCCAM^S .. | 1 0.01 99.03 SHAH SP, GOREN JF, LAZZARA MD, STROMI.. | 1 0.01 99.04 SHARMA H, KESHAVAN A, LIPMAN M, LITTL.. | 1 0.01 99.05 SHARMA H, KESHAVAN A, LIPMAN M, LITTL.. | 1 0.01 99.06 SHARMA P, KRISHNNAMOORTHY P, KURTIS S.. | 1 0.01 99.07 SHARMA TR.. PRIAPISM LASTING 19 HOURS.. | 1 0.01 99.08 SHERRILL M, BURHENN J. PRES SYNDROME .. | 1 0.01 99.09 SHIMAUCHI T, AYA Y, MOTOMATSU S, NAKA.. | 1 0.01 99.10 SHIRAZIAN S, ALI N, FISHBANE S.. TREA.. | 1 0.01 99.11 SIMETKA O, MICHALEC I, CRKVENJAS ZN, .. | 1 0.01 99.12 SINGH A, COPPOCK M, MUKAETOVA-LADINSK.. | 1 0.01 99.13 SINGH NP, SHAH HR, AGGARWAL N, JHA LK.. | 1 0.01 99.14 SINGLA A, AMINI MR, ALPERT MA, GORNIK.. | 1 0.01 99.15 SINGLA M, LINDHOLM P, HODGE D, MOAWAD.. | 1 0.01 99.16 SINKOVIC A, VRBNJAK M, SVENSEK F, KIR.. | 1 0.01 99.17 SMIT L, CUTTING S, CONNERS J, LEE V, .. | 2 0.02 99.19 SODEMANN M. MEDICINE SUBSTITUTION IS .. | 1 0.01 99.20 SOFAS S, SAVOYE G, RAMIREZ S, BAUER F.. | 1 0.01 99.21 SOGAARD ET AL. CLOSTRIDIUM DIFFICILE .. | 1 0.01 99.22 SOGAARD KK, EJLERTSEN T, SCHONHEYDER .. | 1 0.01 99.23 SOKORO AA, ZIVOT J, ARIANO RE. NEUROL.. | 1 0.01 99.24 SPANAKIS EK, SELLMEYER DE. NONUREMIC .. | 1 0.01 99.25 SPENGLER DC, MONTOURIS GD, HOHLER AD... | 1 0.01 99.26 STEFANIOTOU M, VOURDA E, KATSANOS A, .. | 1 0.01 99.27 STEPHEN LJ, KELLY K, PARKER P, BRODIE.. | 1 0.01 99.28 STEVENS, D.C.. EXCHANGE TRANSFUSION I.. | 1 0.01 99.29 STEVENS. EXCHANGE TRANSFUSION IN ACUT.. | 2 0.02 99.31 STUHEC M. TRIMETHOPRIM-SULFAMETHOXAZO.. | 1 0.01 99.32 STUHEC M.. SOLIFENACIN-INDUCED DELIRI.. | 1 0.01 99.33 SUAREZ. CHLORAMPHENICOL TOXICITY ASSO.. | 1 0.01 99.34 SUBRAMANYAM R, CHIDAMBARAN V, DING L,.. | 1 0.01 99.35 SUK KT, KIM DJ, KIM CH, PARK SH, YOON.. | 1 0.01 99.36 SUONTAMA-UUSITALO K, INGO S, JULIN L .. | 1 0.01 99.37 SUZUKI H, SHIGETA A, FUKUNAGA T. ACCI.. | 2 0.02 99.39 SVARSTAD E, HULTSTR?M D, JENSEN D, JE.. | 1 0.01 99.40 T LO, RACAZA GZ, PENSERGA EG.. ^GOLDE.. | 1 0.01 99.41 TADANO T, TAKAHASHI H, SUGAWARA K, SU.. | 1 0.01 99.42 TAKASHI T, SUKISHIRO T, NONOME K, YAS.. | 1 0.01 99.43 TAKU NAKAGAWA ET AL.. TWO CASES OF EM.. | 1 0.01 99.44 TANABE K, TAKEDA H, TOKUKA A, KAGEYA.. | 1 0.01 99.45 TARAZONA-SANTABALBINA FJ, AGUILELLA-F.. | 1 0.01 99.46 TATARA Y, HATTORI Y, MATSUO K, OGINO .. | 1 0.01 99.47 TAYLOR MR, GACO D.. SYMPTOMATIC SINUS.. | 1 0.01 99.48 THOMAS MR, MCDONALD V, MACHIN SJ, SCU.. | 1 0.01 99.49 THORNTON SL, NEGUS E, CARSTAIRS SD.. .. | 1 0.01 99.50 TOMOKO YAJIMA ET AL.. ULCER OF SKIN O.. | 1 0.01 99.51 TOMOYASU TAKEMURA. SEVERE SINUS BRADY.. | 1 0.01 99.52 TRELINSKA J, DACHOWSKA I, KOTULSKA K,.. | 1 0.01 99.53 TRIFANESCU R, VASILICA M, CARSOTE M, .. | 1 0.01 99.54 TRIPATHI R, CHUGH DK, VERMA V, MALA Y.. | 1 0.01 99.55 TROENDLE MM, CUMPSTON KL, POWELL AO, .. | 1 0.01 99.56 TSUJIMOTO, IPPEI. GASTRIC PERFORATION.. | 1 0.01 99.57 TWINE N. DELAYED ONSET OF MALIGNANT H.. | 1 0.01 99.58 UEHARAGUCHI, Y.. A CASE OF PYODERMA G.. | 1 0.01 99.59 UEKI H, IGARASHI S, KIMURA S, TSUCHIM.. | 1 0.01 99.60 UTSUMI T, ET AL.. CASE REPORT: A CASE.. | 1 0.01 99.61 UTSUNOMIYA S, KURIMOTO T.. EFFICACY O.. | 1 0.01 99.62 VAN HUNSEL F, ZWEERS P. INTERACTION B.. | 1 0.01 99.63 VON EULER M, AXELSSON G, HELLDEN A.. .. | 1 0.01 99.64 VROOMAN LM, NEUBERG DS, STEVENSON KE,.. | 1 0.01 99.65 WACHIRA JK, JENSEN CH, RHONE K.. DOXY.. | 1 0.01 99.66 WANG J, GREENBERG H. STATUS CATAPLECT.. | 1 0.01 99.67 WARNKE C., STETTNER M., LEHMENSICK V... | 1 0.01 99.68 WATERMAN NG, TELLIN O, JAMSHIDINIA K,.. | 1 0.01 99.69 WATKINS PB, KAPLOWITZ N, SLATTERY JT,.. | 1 0.01 99.70 WATSON,S. DESLORATADINE AND QT PROLON.. | 1 0.01 99.71 WE KNOW HOW TO PRESCRIBE NATALIZUMAB .. | 1 0.01 99.72 WEBER GM, SMERLING AJ, SAROYAN JM.. P.. | 1 0.01 99.73 WEOTT P, LEONG SP. CARDIOVASCULAR COL.. | 1 0.01 99.74 WIEST, DB. CHLORAMPHENICOL TOXICITY R.. | 1 0.01 99.75 WILDEN S, RUDOLPH B, STANGER C, GRABB.. | 1 0.01 99.76 WITMANOWSKI H, LEWANDOWSKA M, SZYCHTA.. | 1 0.01 99.77 WOCHNA K, JURCZYK AP, KRAJEWSKI W, BE.. | 1 0.01 99.78 WOODS G, TAGGART C, BOGGS R, CADDEN I.. | 1 0.01 99.79 WOZNIAK J, MICK E, WAXMONSKY J, KOTAR.. | 1 0.01 99.80 YAEGASHI Y, NISHIDA J, OYAMA K.. GOUT.. | 1 0.01 99.81 YAGI Y, WATANABE Y, YOKOTE H, AMINO T.. | 1 0.01 99.82 YAJIMA T,JINGU D,SHOJI M,IGARASHI T,W.. | 1 0.01 99.83 YAMADA S, YOTSUEDA H, NAGARA T, GOTO .. | 1 0.01 99.84 YAMAOKA T, AZUKIZAWA H, TANEMURA A, M.. | 1 0.01 99.85 YAMAZAKI S, NAKAMURA F, NANNYA Y, NAK.. | 1 0.01 99.86 YANG J, YANG X, LI M. PERIPHERAL BLOO.. | 1 0.01 99.87 YANG R, YANG Y, XUE F, SHI H, WANG H,.. | 1 0.01 99.88 YARDLEY DA, HART L, WATERHOUSE D, WHO.. | 1 0.01 99.89 YARIS F, KADIOGLU M, KESIM M, ULKU C,.. | 1 0.01 99.90 YILMAZ A, AVCI A, CELIK M, DEMIR K, K.. | 1 0.01 99.91 YOKOTA K ET AL.. A CASE OF SPINAL COR.. | 1 0.01 99.92 YOSHIDA M, OCHI H, HAYASHI T, MATOBA .. | 1 0.01 99.93 YOSUKE TOYOTA. THERAPEUTIC USE OF LOW.. | 1 0.01 99.94 YUKO HIJIOKA. A CASE OF SERIOUS HEPAT.. | 1 0.01 99.95 ZANCANARO A, SERAFINI F, FANTIN G, MA.. | 1 0.01 99.96 ZANCANARO A, SERAFINI F, FANTIN G, MA.. | 1 0.01 99.97 ZHANG X, ZHAO Y.. EXPERIENCE ON THE C.. | 1 0.01 99.98 ZHANG X, ZHAO Y.. EXPERIENCE ON THE C.. | 1 0.01 99.99 ZINNER R, OBASAJU C, SPIGEL D, WEAVER.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017